Back to search

Article

Preventive CGRP ligand monoclonal antibody therapy in refractory adult-onset migraine- associated cyclic vomiting syndrome

2026-03-25

Abstract excerpt

<title>Abstract</title> <p>Cyclic vomiting syndrome (CVS) is a disorder of gut–brain interaction frequently associated with migraine, suggesting overlapping neurobiological mechanisms. However, therapeutic options remain limited in refractory adult patients. Calcitonin gene-related peptide (CGRP) plays a central role in migraine pathophysiology and is also involved in visceral sensory processing, nausea, and auto...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6a650f30-566e-5de2-8b7f-ee33ec52a737
DOI
10.21203/rs.3.rs-8981588/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preventive CGRP ligand monoclonal antibody therapy in refractory adult-onset migraine- associated cyclic vomiting syndromeDOI 10.21203/rs.3.rs-8981588/v1
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity
Cgrp Monoclonal Antibodies: Key Lessons from Real World EvidenceSemantic proximity
Effectiveness and Tolerability of Anti-Calcitonin Gene-related Peptide Therapy for Migraines and Other Chronic Headaches in Adolescents and Young Adults: A Retrospective Study in the USASemantic proximity
Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity
Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention in a real world settingSemantic proximity
Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity
Early Improvement of Affective, Fatigue and Allodynic Symptoms in a Cohort of Resistant Migraineurs Treated with Anti-CGRP/R AntibodiesSemantic proximity
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity
Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients With Migraine: 3 CasesSemantic proximity
Atogepant: Mechanism of action, clinical and translational scienceSemantic proximity
Migraine Treatment: Towards New Pharmacological TargetsSemantic proximity
Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UKSemantic proximity
Select a neighboring publication to make it the new centre.